GEN Exclusives

More »

GEN News Highlights

More »
Feb 28, 2007

Encorium granted $1.2M Contract for Study

  • Encorium Group received a Phase I trial contract for approximately $1.2 million. This contract is in support of an innovative approach to the development of a vaccine for the prevention of multiple types of influenza, including seasonal and pandemic avian flu.

    Encorium will provide consulting on clinical trial design and protocol development, project and study site management and monitoring, data management, and biostatistical support. Revenue recognition will begin in the first quarter of 2007 on a proportional performance basis over the life of the contract as services are performed.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?